Price $11.35 |
Market Cap
284.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
14.44
|
P/S
181.08
|
Dividend %
-
|
|
P/CF
89.4
|
P/FCF
-
|
Op. Cash Flow
-11.7K
|
FCF
-0.8
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-110.40%
|
ROI
-78.30%
|
|
ROA
-83.70%
|
EPS Growth
35.30%
|
Current Ratio
5.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aquinox Pharmaceuticals Inc (AQXP) | $2.60 | - | - | 68M | Strong Buy |
| American Renal Associates Hold (ARA) | $19.40 | - | - | 702.9M | Strong Buy |
| Acorda Therapeutics Inc (ACOR) | $18.23 | - | - | 914.1M | Strong Buy |
| Digirad Corporation (DRAD) | $1.39 | - | 14.70% | 31.2M | Strong Buy |
| Neurometrix Inc (NURO) | $1.29 | - | - | 9.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
